Researchers use AI to break the rules of nature and create a living organism that lacks a fundamental building block of life – the first synthetic 19-amino acid life form is here
Researchers from Columbia University, the Massachusetts Institute of Technology, and Harvard University have successfully harnessed AI to engineer a novel strain of E. coli bacteria that defies conventional biological norms by lacking one of the twenty standard amino acids integral to all known life forms. By specifically removing isoleucine from the ribosome—the cellular machinery responsible for protein synthesis—they created the first organism that operates with only nineteen amino acids, marking a groundbreaking achievement in both synthetic biology and AI-driven research.
This research, outlined in a recent publication, challenges longstanding assumptions about the immutable nature of the genetic code, which has historically involved twenty universal amino acids. While it has been known that some species incorporate additional amino acids, no naturally occurring organism has been identified with fewer than twenty. The study leverages AI protein language models to predict alternative protein configurations, enabling substitution of amino acids within the ribosome without compromising functionality. Isoleucine was chosen for removal due to its chemical similarity to leucine and valine, making it the most amenable candidate for replacement without critical functional loss.
In contrast to previous work focused on adding amino acids to genetic codes, this endeavor uniquely accomplished amino acid elimination by editing 382 isoleucine sites within the ribosome. Among fifty engineered E. coli strains with isoleucine replaced by alternative amino acids, eighteen exhibited normal growth, with a composite strain incorporating 21 rewritten ribosomal proteins eventually demonstrating viability, albeit with slower growth relative to unmodified strains. This success signals that critical biological systems possess a latent tolerance for significant genetic code changes.
These findings offer compelling evidence in support of hypotheses positing that primitive life forms might have relied on a reduced amino acid set, enriching evolutionary biology discourse. Beyond theoretical implications, the study sets a precedent for developing bespoke synthetic organisms tailored for specialized medical and healthcare functions. Such custom organisms might exhibit dependency on non-natural chemistries, thereby enhancing containment and biosafety. Looking forward, AI-assisted genetic manipulation has potential applications in designing life forms optimized for extreme environments, including extraterrestrial habitats where access to a full spectrum of amino acids may be restricted.
